A major new antiviral drug development center led by Scripps Research in La Jolla to prime for the next pandemic is getting a $67 million award over three years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, with potential renewal for two additional years.
NIH announces antiviral drug development awards miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.